Designing & Implementing a Robust Clinical Program For Anaemia in CKD & Update on Clinical Data

Time: 4:30 pm
day: Day Two


  • Study design considerations development of drugs for anaemia caused by chronic kidney disease
  • Explore the adaptations of study design and execution in the time of COVID – lessons learned for the future conduct of clinical studies
  • Get an update on clinical data for the phase 3 studies for Daprodustat